NCT06442553

Brief Summary

Low level laser treatments have been used to treat painful trigger points in myofascial pain syndrome (MPS), but the effectiveness of the appropriate laser type and parameters is still uncertain. The aim of this study was to compare the effectiveness of different types of low level laser treatment (LLLT) in reducing pain levels, changing oxygen saturation and bite force in patients with MPS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2024

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 4, 2024

Completed
Last Updated

June 4, 2024

Status Verified

May 1, 2024

Enrollment Period

2 months

First QC Date

May 29, 2024

Last Update Submit

May 29, 2024

Conditions

Keywords

low level laser therapymyofascial pain syndromebite forcesvisual analogue scalegaalas laserneodymium doped yttrium aluminum garnet lasers

Outcome Measures

Primary Outcomes (3)

  • change from baseline in pain on the 10 point visual analogue scale (VAS) at week 3

    Patients were asked to rate the intensity of their pain on a scale from 0 to 10. They were told that a score of 0 meant no pain, a score of 10 meant severe pain and a score of 5 meant moderate pain

    baseline and week 3

  • change from baseline in oxygen concentration in the massater muscle at week 3

    oxygen concentration in the massater muscle was measured by functional near-infrared spectroscopy- fNIRS (ARGES cerebro, Hemosoft Inc., Ankara, Turkey) before and after treatment for each patient.

    baseline and week 3

  • change from baseline in bite force values at week 3

    bite force values were recorded by Flexiforce sensors before and after treatment for each patient.

    baseline and week 3

Study Arms (3)

GRR laser

EXPERIMENTAL

patients received 15 sessions GRR laser treatment for 3 weeks

Device: GRR laser

Nd:YAG Laser

EXPERIMENTAL

patients received 10 sessions Nd:YAG laser treatment for 2 weeks

Device: Nd:YAG laser

placebo

PLACEBO COMPARATOR

patients received 10 sessions emission-free laser treatment for 2 weeks

Device: Nd:YAG laser

Interventions

GRR laserDEVICE

A total of 15 sessions were applied to each patient for three weeks, five times per week.

GRR laser

A total of 10 sessions, five sessions per week, were applied

Nd:YAG Laserplacebo

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • patients with symptoms of temporomandibular disorders and diagnosed with MPS as a result of the clinical examination.

You may not qualify if:

  • Patients with internal TMJ irregularities or degenerative joint changes,
  • patients with restricted mouth opening, deviation or deflection,
  • patients with systemic diseases,
  • pregnant women,
  • patients who had received MPS treatment within the previous year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İrem Karagözoğlu

Şehitkamil, Gazi̇antep, 27310, Turkey (Türkiye)

Location

Related Publications (1)

  • Karagozoglu I, Demirkol N, Parlar Oz O, Yilmaz S, Ozcan M. New generation low level laser effect on masseter muscle oxygenation, bite force and algometric changes in myofacial pain syndrome: a randomised, placebo-controlled clinical trial. Lasers Med Sci. 2025 Jan 27;40(1):48. doi: 10.1007/s10103-024-04272-z.

MeSH Terms

Conditions

Myofascial Pain Syndromes

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal Diseases

Study Officials

  • İREM KARAGÖZOĞLU

    GAZİANTEP ÜNİVERSİTESİ DİŞ HEKİMLİĞİ FAKÜLTESİ

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist. Prof.

Study Record Dates

First Submitted

May 29, 2024

First Posted

June 4, 2024

Study Start

January 15, 2024

Primary Completion

March 25, 2024

Study Completion

April 1, 2024

Last Updated

June 4, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations